Transcept Pharmaceuticals (TSPT) Earnings
|
Expand Research on TSPT
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +57.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/13/14 | Q413 | -$0.29 | -$0.21 | -$0.08 | $316K | $500K | N/A |  | | Details | |
| 2/27/13 | Q412 | -$0.35 | -$0.28 | -$0.07 | N/A | N/A | N/A | | | Details | |
11/12/12  |
Q312 | $0.25 | $0.06 | +$0.19 | $10.44M | $8.37M | N/A | | | Details | |
| 8/13/12 | Q212 | -$0.30 | -$0.24 | -$0.06 | $500K | $1.87M | N/A | | | Details | |
| 5/14/12 | Q112 | -$0.37 | -$0.54 | +$0.17 | N/A | N/A | N/A | | | Details | |
| 3/14/12 |
 |
Q411 | $0.37 | N/A | N/A | $12.8M | $3.13M | N/A | | | Details |
| 11/10/11 |
|
Q311 | -$0.37 | -$0.33 | -$0.04 | $625K | $520K | N/A | | | Details |
| 8/11/11 | Q211 | -$0.17 | -$0.23 | +$0.06 | $3.13M | $2.08M | N/A | | | Details |
